Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: An evaluation of 212 cases

Acta Oncologica

Volumn 45, Issue 6, 2006, Pages 669-675

  Luukkaa, Heikki ^a   Klemi, Pekka ^b   Leivo, Ilmo ^c   Vahlberg, Tero ^b   GréNman, Reidar ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

AGE; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; FEMALE; FINLAND; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SALIVARY GLAND TUMOR; SEX DIFFERENCE; SURVIVAL RATE;

AGE FACTORS; FEMALE; FINLAND; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SEX FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250798545     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860500543208     Document Type: Article

References (23)

1. Vander Poorten VL. Salivary gland carcinoma-Stepping up the prognostic ladder. Amsterdam: University of Amsterdam; 2002. p. 222
2. Finnish Cancer Registry. May 12th 2005. Available from: URL: http://www.cancerregistry.fi/tilastot/
3. Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Makitie A, et al. Salivary gland cancer in Finland 1991-96: An evaluation of 237 cases. Acta Otolaryngol 2005;125(2): 207-14 (Pubitemid 40293215)
4. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: Clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 1994;25(9):929-35 (Pubitemid 24292411)
5. Skalova A, Leivo I, von Boguslawsky K, Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas in salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol 1994;173(1):13-21 (Pubitemid 24182256)
6. Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M, Viale G. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997;181(3):323-9 (Pubitemid 27156847)
7. Nordgård S, Franzen G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997;107(4):531-6 (Pubitemid 27176065)
8. Kiyoshima T, Shima K, Kobayashi I, Matsuo K, Okamura K, Komatsu S, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 2001;37(3):315-22 (Pubitemid 32245858)
9. Xin W, Paulino AF. Prognostic factors in malignant mixed tumors of the salivary gland: Correlation of immunohistochemical markers with histologic classification. Ann Diagn Pathol 2002;6(4):205-10
10. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351(6326):453-6 (Pubitemid 21896613)
11. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408(6810):307-10
12. Haapasalo H, Pesonen E, Collan Y. Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms. Pathol Res Pract 1989; 185(5):551-4 (Pubitemid 20076915)
13. Seifert SG. Histological typing of salivary gland tumours. WHO International Histological Classification of Tumours, 2nd ed. Berlin: Springer; 1991
14. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumours, 5th ed. New York: John Wiley & Sons, Inc.; 1997
15. Ellis GL, Auclair PL. Atlas of tumor pathology, tumors of the salivary glands. In: series 3 f, editor. Washington, DC.: Armed Forces Institute of Pathology; 1996. p. 163
16. Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25(7):835-45 (Pubitemid 32594976)
17. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82(7):1217-24 (Pubitemid 28155381)
18. Kärjä VJ, Syrjänen KJ, Kurvinen AK, Syrjänen SM. Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med 1997;26(5):217-23 (Pubitemid 27324325)
19. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 1995;75(8):2037-44
20. Soini Y, Kamel D, Nuorva K, Lane DP, Vahakangas K, Päkkö P. Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch A Pathol Anat Histopathol 1992;421(5):415-20
21. Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H. Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med 1999;28(6):259-63 (Pubitemid 29298249)
22. Zhu QR, White FH, Tipoe GL. p53 oncoprotein accumulation in adenoid cystic carcinoma of parotid and palatine salivary glands. Pathology 1997;29(2):154-8 (Pubitemid 27296462)
23. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, et al. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 2003;32(9):552-61 (Pubitemid 37175008)